Home › Funds › Integral Health Asset Management, LLC › EWTX
Integral Health Asset Management, LLC position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
Integral Health Asset Management, LLC reported holding 300,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 0.79% of its reported portfolio and ranking #41 among its reported holdings. Integral Health Asset Management, LLC has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Integral Health Asset Management, LLC's EWTX position evolved
Integral Health Asset Management, LLC first disclosed a stake in EWTX in Q3 2024 at 500,000 shares (US$13.3M). The position peaked in Q2 2026 at 2,000,000 shares, worth US$81.3M. Across 9 filings, Integral Health Asset Management, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 300,000 shares valued at US$12.2M — a reduction of -1,700,000 shares quarter over quarter.. Notable position changes include a 233% increase in Q2 2025 (shares rose 24% over the following quarter), a 50% increase in Q3 2025 (shares rose 53% over the following quarter), a 85% trim in Q3 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 500.00K | $13.35M | New |
| Q4 2024 | 300.00K | $8.01M | Reduce |
| Q1 2025 | 300.00K | $6.60M | Hold |
| Q2 2025 | 1.00M | $13.11M | Add |
| Q3 2025 | 1.50M | $24.33M | Add |
| Q4 2025 | 1.50M | $37.22M | Hold |
| Q1 2026 | 1.60M | $50.40M | Add |
| Q2 2026 | 2.00M | $81.26M | Add |
| Q3 2026 | 300.00K | $12.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.78M sh · $437.61M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.40M sh · $178.72M · Q3 2026
- PERCEPTIVE ADVISORS LLC 4.37M sh · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Siren, L.L.C. 2.80M sh · $113.85M · Q3 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- BRAIDWELL LP 2.00M sh · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
- Deep Track Capital, LP 1.15M sh · $46.64M · Q3 2026
More on Integral Health Asset Management, LLC
FAQ
How long has Integral Health Asset Management, LLC held EWTX?
Integral Health Asset Management, LLC has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Integral Health Asset Management, LLC's current position in EWTX?
As of Q3 2026, Integral Health Asset Management, LLC holds 300.00K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $12.18M, representing 0.79% of its reported portfolio and ranking #41.
Has Integral Health Asset Management, LLC been buying or selling EWTX?
In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC reduced its position in EWTX. The position peaked in Q2 2026 at 2.00M shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.